title: Sorafenib treatment in 13 patients with acute myeloid leukemia and activating FLT3 mutations in combination with chemotherapy or as monotherapy.
authors.affiliation: University of Duesseldorf, Medical Faculty, Department of Haematology, Oncology and Clinical Immunology, Duesseldorf, Germany. thomas.schroeder@med.uni-duesseldorf.de
authors.forename: Thomas
authors.initials: T
authors.lastname: Schroeder
authors.forename: Fabian
authors.initials: F
authors.lastname: Zohren
authors.forename: Christian
authors.initials: C
authors.lastname: Saure
authors.forename: Ingmar
authors.initials: I
authors.lastname: Bruns
authors.forename: Akos
authors.initials: A
authors.lastname: Czibere
authors.forename: Nelli Nancy
authors.initials: NN
authors.lastname: Safaian
authors.forename: Roland
authors.initials: R
authors.lastname: Fenk
authors.forename: Rainer
authors.initials: R
authors.lastname: Haas
authors.forename: Guido
authors.initials: G
authors.lastname: Kobbe